Publication:
Letter to Editor: Role of Pharmacotherapy in Patients With Coexisting Nonalcoholic Fatty Liver Disease and Type 2 Diabetes Mellitus

dc.contributor.authorSikarin Upalaen_US
dc.contributor.otherFaculty of Medicine, Siriraj Hospital, Mahidol Universityen_US
dc.date.accessioned2020-01-27T09:51:16Z
dc.date.available2020-01-27T09:51:16Z
dc.date.issued2019-05-01en_US
dc.identifier.citationHepatology. Vol.69, No.5 (2019), 2303-2304en_US
dc.identifier.doi10.1002/hep.30551en_US
dc.identifier.issn15273350en_US
dc.identifier.issn02709139en_US
dc.identifier.other2-s2.0-85064197250en_US
dc.identifier.urihttps://repository.li.mahidol.ac.th/handle/20.500.14594/51670
dc.rightsMahidol Universityen_US
dc.rights.holderSCOPUSen_US
dc.source.urihttps://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85064197250&origin=inwarden_US
dc.subjectMedicineen_US
dc.titleLetter to Editor: Role of Pharmacotherapy in Patients With Coexisting Nonalcoholic Fatty Liver Disease and Type 2 Diabetes Mellitusen_US
dc.typeLetteren_US
dspace.entity.typePublication
mu.datasource.scopushttps://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85064197250&origin=inwarden_US

Files

Collections